Vontobel Holding Ltd. Biocryst Pharmaceuticals Inc Transaction History

Vontobel Holding Ltd.

  • $29.4 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 29, 2021
SELL
$14.21 - $17.65 $99,470 - $123,549
-7,000 Reduced 13.78%
43,800 $629,000
Q2 2021

Aug 06, 2021
BUY
$9.5 - $17.24 $142,500 - $258,599
15,000 Added 41.9%
50,800 $803,000
Q4 2020

Feb 12, 2021
BUY
$3.37 - $8.61 $120,646 - $308,238
35,800 New
35,800 $267,000

Others Institutions Holding BCRX

# of Institutions
257
Shares Held
173M
Call Options Held
397K
Put Options Held
444K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.52B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email